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Proteomic dissection of LPS-
inducible, PHF8-dependent 
secretome reveals novel roles 
of PHF8 in TLR4-induced 
acute inflammation and T cell 
proliferation
Özgün Erdoğan1, Ling Xie1, Li Wang1,2, Bing Wu3, Qing Kong1, Yisong Wan3,4 & Xian Chen1,2,4
Endotoxin (LPS)-induced changes in histone lysine methylation contribute to the gene-specific 
transcription for control of inflammation. Still unidentified are the chromatin regulators that drive 
the transition from a transcriptional-repressive to a transcriptional-active chromatin state of pro-
inflammatory genes. Here, using combined approaches to analyze LPS-induced changes in both gene-
specific transcription and protein secretion to the extracellular compartment, we characterize novel 
functions of the lysine demethylase PHF8 as a pro-inflammatory, gene-specific chromatin regulator. 
First, in the LPS-induced, acute-inflamed macrophages, PHF8 knockdown led to both a reduction of 
pro-inflammatory factors and an increase in a transcriptional-repressive code (H3K9me2) written by the 
methyltransferase G9a. Through unbiased quantitative secretome screening we discovered that LPS 
induces the secretion of a cluster of PHF8-dependent, ‘tolerizable’ proteins that are related to diverse 
extracellular pathways/processes including those for the activation of adaptive immunity. Specifically, 
we determined that PHF8 promotes T-cell activation and proliferation, thus providing the first link 
between the epigenetic regulation of inflammation and adaptive immunity. Further, we found that, in 
the acute-inflamed macrophages, the acute-active PHF8 opposes the H3K9me1/2-writing activity of 
G9a to activate specific protein secretions that are suppressed by G9a in the endotoxin-tolerant cells, 
revealing the inflammatory-phenotypic chromatin drivers that regulate the gene-specific chromatin 
plasticity.
Activation of inflammation, the key host innate immune response to microbial challenge1, is a double-edged 
sword; it protects the host from infection and cellular damage, yet, its deregulation contributes directly to various 
inflammation-associated pathologies2,3. Previous studies indicated that control of inflammation is achieved by 
endotoxin- or lipopolysaccharide (LPS)-induced gene-specific chromatin modifications. The landscape of pro-
moter chromatin modifications is differentially programmed for a class of pro-inflammatory or “tolerizeable” 
(T-class) genes, in correlation with either acutely or chronically inflamed nature or “inflammatory-phenotype” 
of the stimulated cells4. However, how inflammation-phenotypic plasticity is regulated within the chromatin of 
pro-inflammatory genes is poorly understood.
The properties of histones, the core components of chromatin, can be altered by different post-translational 
modifications (PTMs) that specify whether the promoter of associated gene is in an open/active or closed/
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repressed chromatin state, thereby dictating specific biological outcomes such as an inflammatory response5. 
Histone lysine methylation (Kme) patterns indicate chromatin architecture/state of either activated or repressed 
transcription of associated genes. Particularly on histone H3, methylated H3K9 and H3K27 are associated mostly 
with gene repression6. Meanwhile, in a defined chromatin state, the level of each Kme is tightly regulated by spe-
cific lysine methyltransferases (KMTs) and lysine demethylases (KDMs). The KMT G9a plays a critical regulatory 
role in promoting ET by di-methylating H3K9 in the promoters of “T-class” genes7 and by changing the global 
Kme landscape, chromatin remodeling, and activities of select transcription factors8. Meanhwile, we discovered 
that protein phosphatase 2A (PP2Ac) is a broad chromatin-associated regulator of ET, which participates in the 
establishment of inflammatory-phenotypic chromatin modifications for specific classes of genes9: in ET mac-
rophages plant homeodomain finger protein 8 (PHF8), a histone KDM, contains notable PP2Ac-target sites.
PHF8 is a Jumonji-C-domain-containing KDM that demethylates H3K9me1/2 or H3K27me2 or 
H4K20me1/210, and functions as a transcriptional regulator mostly in brain development, cell cycle, cytoskeleton, 
and cell proliferation11–13. However, little is known about its inflammation-associated function. A recent study 
indicates a phosphorylation-dependent activation of PHF8 for erasing H3K9me212. Our coincident finding that 
chronic-active PP2Ac targets the same serine residue whose phosphorylation is associated with activated PHF8 
has generated a hypothesis that PP2Ac-mediated dephosphorylation of PHF8 would inhibit its KDM activity in 
ET macrophages. By performing various biochemical, biological, and immunological experiments, we discovered 
that the H3K9me2-erasing activity of PHF8 defines the inflammatory phenotype of the macrophages exposed to 
an acute LPS stimulation through reprogramming chromatin modifications that favor transcriptional activation 
of pro-inflammatory genes.
Because the end products of the host innate immune response are specific proteins secreted from inflam-
matory cells that play a direct messenger role in regulating overall immunity14, we designed an unbiased 
label-free-quantitative (LFQ) proteomic experiment8,15 to systematically investigate the extracellular functions 
of PHF8. By using LFQ to compare the time-resolved profiles of proteins that are secreted from paired wild-type 
(WT) versus PHF8 knock-down (PHF8-KD) RAW 264.7 cells following LPS stimulation, we identified a novel 
cluster of the ‘tolerizable’ (T-class) proteins that were secreted in an LPS-inducible, PHF8-dependent manner. 
We then systematically revealed that PHF8 is a pro-inflammatory chromatin regulator of a broad range of the 
genes and associated biological processes/pathways. This dataset of the LPS-inducible, PHF8-dependent, T-class 
secretome not only identifies a large number of PHF8-regulated pro-inflammatory cytokines, but also extends 
our knowledge of novel PHF8 functions that regulate acute inflammation and overall immunity, including the 
activation of adaptive immunity.
For the first time, we identified the epigenetic regulatory link between the innate immune response and the 
activation of adaptive immunity where the LPS-induced secretion of specific proteins involved in the associ-
ated T-cell activation/proliferation is PHF8-dependent. Our data also showed that, under an acute inflammatory 
condition, the gene-specific-repressive function of the Kme writer G9a is antagonized by the Kme eraser PHF8, 
elucidating the mechanism underlying the gene-specific chromatin plasticity that corresponds to changes in cel-
lular immune responses to LPS stimulation(s). Our quantitative proteomic strategy to dissect LPS-inducible, 
inflammatory-phenotypic secretome has led us to discover novel PHF8 functions that control inflammation 
and overall immunity at the post-translational level. These findings are highly physiological-relevant and are 
not accessible by conventional transcriptome approaches. Thus, this secretome screening method generates the 
simultaneous multi-target quantitative datasets without the need of antibodies on mass spectrometry, which is 
otherwise equivalent to that of hundreds or thousands of ‘western blots’ or ELISA.
Results
The KDM activity of PHF8 is altered or suppressed by PP2Ac in the reprogramed chromatin 
under chronic inflammatory conditions. To determine the pathways and biological processes (BPs) that 
are targeted/modulated by PP2Ac, we used an amino-acid-coded mass tagging (AACT)-based quantitative phos-
phoproteomic approach16 to comparatively analyze changes in site-specific phosphorylation levels in WT versus 
PP2Ac-KD RAW 264.7 cells, which led to identifications of the protein substrates directly or indirectly targeted by 
chronically activated PP2Ac (Supplementary Fig. 1a). Multiple protein components involved in multiple chroma-
tin-associated BPs showed significantly enhanced phosphorylation in PP2AcKD-TL compared to WT-TL, indi-
cating that each of these proteins contains phosphorylation site(s) that could be dephosphorylated by chronically 
active PP2Ac in ET macrophages (Fig. 1a and Supplementary Fig. 1b). Some of these proteins, including Histone 
deacetylases 1/2 (HDAC1/2), DNA methyltransferase 1 (DNMT1), and methyl-CpG binding protein 2 (MeCP2), 
were previously characterized as the major components of co-repressor complexes. Our quantitative phosphop-
roteomic data showed that PP2Ac dephosphorylates the transcription-regulating S421/423 pair of HDAC117 
to inhibit dimerization with HDAC2 in the transcriptionally repressive chromatin state (Supplementary Fig. 
1c, top). Also, we found that the epigenetic regulator MeCP2 was dephosphorylated by PP2Ac at phosphoS80 
that is associated with induction of apoptotic genes18 (Supplementary Fig. 1c, bottom). Strikingly, associat-
ing with these PP2Ac-mediated chromatin reprogramming, we identified three serine residues (S768, S820, 
and S843) within or near the serine-rich region of the PHF8 (Supplementary Fig. 1d) that showed increased 
phosphorylation in PP2AcKD-TL compared with phosphorylation in WT-TL (Supplementary Fig. 1e,f ), 
indicating that chronically activated PP2Ac may dephosphorylate PHF8 in ET.
To determine if the KDM activity of PHF8 could be affected in ET macrophages by chronic-active PP2Ac, 
we examined how knockdown of PP2Ac correlates with the methylation level of these PHF8-target Kme sites, 
the transcriptionally repressive PTMs in particular, including H3K9me1/2 and H3K27me210. As shown in 
Fig. 1b, PP2AcKD caused decreased levels of both H3K9me1/2 and H3K27me2 compared with WT cells, and 
the decrease in the site-specific methylation on H3 was more dramatic under ET (Note the lanes at 15 and 30 min 
comparing PP2Ac-KD versus WT). Notably, the level of H3K27me3, which is not a target of PHF8, remained 
www.nature.com/scientificreports/
3Scientific RepoRts | 6:24833 | DOI: 10.1038/srep24833
unchanged as expected, indicating that the KDM activity of PHF8 is indeed suppressed in the PP2Ac-dependent 
way specifically under the ET chronic inflammatory condition.
PHF8 erases the transcriptionally repressive H3K9me2 and up-regulates NFκB-dependent 
pro-inflammatory genes in the acutely inflamed macrophages. As the first step to characterize 
the inflammatory-associated function of PHF8, we first established a pair of stable cell lines expressing shRNA 
against GFP (shCON or WT) or against PHF8 (shPHF8 or PHF8-KD). We used immunoblotting to confirm the 
inflammatory-phenotype of PHF8-KD (Supplementary Fig. 2, left), as PHF8-KD efficiency was found at 70% by 
quantitative PCR (qPCR) (Supplementary Fig. 2, right). Also, immunoblotting revealed that in WT cells PHF8 
mRNA and protein levels both decreased with 24 hours of LPS stimulation, supporting our data-derived hypoth-
esis that PHF8 is suppressed with prolonged LPS stimulation or in ET.
Because both the levels of phosphoserine 10 (H3pS10) and K9me1/2 of histone H3 specifically mark the 
transcriptional activity status of select genes4, we examined the LPS-induced time-dependent changes in the 
H3pS10 and PHF8-target Kme sites by performing immunoblotting experiments. First, we observed that at 
each time point following an acute LPS stimulation the LPS-induced level of H3pS10 was significantly lower in 
PHF8-KD cells vs. WT cells (Fig. 2), indicating knocking down PHF8 reduces the overall inflammatory response of 
LPS-stimulated macrophages. Further, in the WT macrophages, among the PHF8-targeted Kme sites on histone 
H3, both H3K9me2 and H3K9me1 showed significant decreases at the early time points following an acute LPS 
Figure 1. The KDM activity of PHF8 in the chromatin regulator complexes is altered or suppressed by PP2Ac 
under chronic inflammatory conditions (a) IPA network analysis revealed the canonical pathways involving 
the chromatin proteins that showed the highest increase in PP2Ac-dependent, site-specific phosphorylation 
in LPS-tolerant macrophages. (b) Immunoblot analysis of the effects of the inflammatory phenotype-specific 
levels of various Kme sites altered by PP2Ac knockdown (PP2Ac-KD). Paired WT and PP2Ac-KD RAW 
cells were respectively stimulated by LPS for indicated length (0, 5, 15, and 30 min) (Left). The level changes 
of PHF8-target Kme were quantitatively determined by a scanning densitometry (Right, H3K9me2 in blue 
and H3K27me2 in red). ‘NL’ refers to acutely stimulated, and ‘TL’ indicates the re-stimulation of the primed 
macrophages. This immunoblot is a representation of 3 biological replicates, and individual gels were separately 
run under the same experimental conditions.
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stimulation (Fig. 2), in contrast to the increased levels at the same time points in PHF8-KD cells. Meanwhile, the 
level of H3K27me2 slightly decreased.
Phosphorylation of p65 at Ser536 (P-p65) marks the pro-inflammatory transactivation of the transcription 
factor NFκ B as well as the accessibility of NFκ B to select gene promoters19. Our previous study showed that 
chronically active PP2Ac dephosphorylates Ser536, leading to reduced transactivation and promoter accessi-
bility by NFκ B9. Here, while the total p65 amount was similar in both WT and PHF8-KD, the LPS-inducible 
time-dependent level of P-p65 was lower in PHF8-KD than in WT (Fig. 2, Supplementary Fig. 2). Further, we 
found that this decrease in p65 phosphorylation upon PHF8 knockdown occurred primarily on the p65 that was 
translocated into the nucleus (Fig. 3a). To clarify whether PHF8 affects p65 phosphorylation, either directly or 
indirectly, we examined p65 or PHF8 immunoprecipitates (Fig. 3b): P-p65 was maximally phosphorylated in the 
PHF8 immunoprecipitate from the macrophages following acute LPS stimulation (30 min), but reduced with 
prolonged stimulation (Fig. 3b). Since NFκ B activity is regulated by lysine methylation20, our results suggested 
that PHF8 may promote the transactivation of NFκ B during acute inflammation through PHF8-mediated lysine 
demethylation of NFκ B. This is also supported by a recent report that another KDM PHF20 maintains the active 
state of NFκ B21.
We then evaluated the contribution of PHF8, or the NL-specific interaction between PHF8 and p65, 
on LPS-induced transcriptional activity of p65 by performing dual-luciferase reporter assays. Clearly, the 
LPS-induced NFκ B activity was reduced in the PHF8-KD cells compared to WT cells, indicating that PHF8 pos-
itively regulates LPS-induced transcriptional activity of NFκ B in acutely inflamed cells (Fig. 3c).
Since PHF8 directly regulates LPS-inducible, phosphorylation-dependent transactivation of NFκ B in acutely 
inflamed cells, we next investigated the impact of PHF8 activity on the transcription of select pro-inflammatory 
genes. Thus, we compared the cytokine expression of paired WT and PHF8-KD cells with either no stimulation 
or 1 mg/mL LPS stimulation for 1/4, 2, 4, 8, and 24 h (Fig. 3d). First, we confirmed the inflammatory phenotype of 
each time point by immunoblotting the indicated markers (Fig. 3d, top), followed by measuring mRNA levels of 
the indicated genes. In WT macrophages, LPS stimulation increased the mRNA expression of pro-inflammatory 
cytokines whereas in PHF8-KD cells we observed a decrease in most of these cytokines (Fig. 3d, bottom). PHF8 
mRNA expression paralleled cytokines expression; in WT cells, PHF8 mRNA expression following LPS stimu-
lation was high until 2 h, then decreased below basal levels after 2 h, and was lowest after 4 h. This time course 
supports the notion that PHF8 functions as a transcriptional activator of select cytokines upon acute LPS stim-
ulation; its expression is decreased in ET to increase repressive H3K9me2 in conjunction with immunosuppres-
sion. Importantly, Interfeuron β (IFNβ) , which was the only cytokine to show significantly higher LPS-induced 
mRNA expression in the PHF8-KD cells, can act as an inhibitor of inflammation22. Thus, in PHF8-KD cells, the 
increased mRNA expression of IFNβ in combination with decreased mRNA expression of pro-inflammatory 
cytokines implies that PHF8-dependent activation of cytokines is both gene-specific and pro-inflammatory 
phenotype-specific. Because these cytokines are regulated by NFκ B, our data demonstrate that PHF8 positively 
Figure 2. PHF8 plays a pro-inflammatory role in LPS-induced, acutely inflamed macrophages by reducing 
the levels of H3 K9me1/2. Site-specific lysine methylations on H3 were comparably analyzed in paired WT 
(shCON) versus PHF8-KD (shPHF8) RAW 264.7 cells using immunoblotting. The macrophages were collected 
at the indicated time points of LPS stimulation (1/4, 2, 8, and 24 h). This immunoblot is a representation of 3 
biological replicates, and individual gels were separately run under the same experimental conditions.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:24833 | DOI: 10.1038/srep24833
regulates LPS-induced, NFκ B-dependent transcription of select pro-inflammatory genes. It should be noted 
that different cytokines/chemokines exhibited activated or PHF8-dependent mRNA expression at different time 
points after LPS stimulation.
PHF8 selectively promotes the secretion of a specific group of ‘tolerizable’ proteins including 
cytokines and chemokines. To understand how PHF8 directly regulates LPS-induced inflammation 
and overall immune response and to identify the associated BPs and pathways, we employed an unbiased LFQ 
proteomic method8,15 to profile the LPS-induced, time-resolved proteins that are differentially secreted from 
paired WT versus PHF8-KD RAW cells (Fig. 4a). This non-biased, discovery-driven secretome screening can 
identify not only PHF8-regulated secretory proteins but also unknown extracellular functions of PHF8 that 
control inflammation. We therefore stimulated WT and PHF8-KD RAW cells with LPS for 0, 2, 4, 8, and 24 h; 
Figure 3. PHF8 is a positive chromatin regulator of NFκB transactivation. (a) Immunoblot analysis of 
the p65 and P-p65 abundance in the cytosol and nucleus of paired WT (shCON) and PHF8-KD (shPHF8) 
cells with LPS stimulation for indicated duration (0, 1/4, 1, and 24 h). The gels were run under same 
experimental conditions and sample loading. (b) PHF8 forms a nucleus-specific complex with p65 in the 
acutely LPS-stimulated WT cells, and the complex formation is enhanced with an acute LPS stimulation. 
Immunoprecipitations using the antibody against p65 or PHF8 were performed respectively for the nuclear 
fraction (Fig. 3a, left) of WT (shCON) versus PHF8-KD (shPHF8) RAW cells were collected at the indicated 
time points following an acute LPS stimulation (1/4, 1/2, 1, 24 h). Immunoblotting experiments were conducted 
with indicated antibody. (c) PHF8-KD leads to reduced NFκ B activity. 293-TLR4-MD2-CD14 cells stably 
expressing WT (shCON) or PHF8-KD (shPHF8) were transfected with Firefly luciferase. 24 hours after the 
transfection, the cells were stimulated with 1μg/ml LPS and were collected at 0, 6, 8, or 12 h with three biological 
replicates. The activity of each sample was normalized to Renilla luciferase. Each column shows mean ± s.e. of at 
least three independent experiments. *P < 0.05 compared with mock-transfected cells (Student’s t-test).  
(d) PHF8 regulates the expression of select pro-inflammatory cytokines. Immunoblot analysis was conducted to 
monitor indicated inflammatory markers (top). qPCR analysis (bottom) shows the mRNA expression of select 
proinflammatory cytokines in paired WT (shCON, dark grey bars) and PHF8-KD (shPHF8, light grey bars) 
with LPS stimulation while error bars show the mean ± s.e. of three independent experiments. Time points are 
indicated for the non-stimulated (0 h) and stimulated RAW cells (0.25, 2, 4, 8, and 24 h).
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representing non-stimulated (N), acutely stimulated (NL), and prolonged stimulated (T) inflammatory states 
(Fig. 4a). Following our protocol8, we collected the culture supernatants containing proteins secreted from WT 
and PHF8-KD cells with either N, or NL, or T phenotype, while the cell pellets were assayed by immunoblotting 
for the levels of phospho-p65, Iκ Bα , and phospho-Iκ Bα (Supplementary Fig. 3a). An LFQ analysis was then per-
formed on two biological replicates, in which each biological set was further measured with three technical rep-
licates. The time-resolved or inflammatory-phenotypic changes in the amounts of secreted proteins were filtered 
to proteins with a 5% permutation-based false-discovery-rate (FDR) and normalized for all inflammatory states 
according to the Z-score. The correlation between different replicates was confirmed with a Pearson correlation 
analysis (score > 0.7) (Supplementary Fig. 3b).
Figure 4. PHF8 regulates a broad range of the extracellular functions of acute LPS-stimulated 
macrophages through modulating the LPS-induced secretion of specific class of proteins. (a) Workflow 
and experimental design of LFQ secretome analysis to identify/profile the proteins that are differentially 
secreted into the media from paired WT (shCON) versus PHF8-KD (shPHF8) cells with LPS stimulation. WT 
and PHF8-KD RAW cells were cultured in serum-free media and stimulated with LPS for 0, 2, 4, 8, and 24 h. 
The extracellular media was used for MS/MS while cell pellets were used to confirm inflammatory phenotype 
as shown in Supplementary Fig. 3a. (b) The LFQ secretome heatmap of the differentially secreted proteins 
from paired WT (shCON) and PHF8-KD (shPHF8) RAW 264.7 macrophages under different inflammatory 
conditions. The color key (right bottom) indicates LPS-induced changes (increase in red, decrease in green) in 
secretion of proteins in logarithmic scale. Time points are indicated for the non-stimulated (0 h) and stimulated 
cells (8 and 24 h). (c) The comparison of the secretome analysis with previous BMDM secretome studies8,15. 
Top panel shows the comparison of all secreted proteins while the bottom panel shows the comparison of 
LPS-induced secreted proteins. The present study of the secretome is represented by a light grey circle while 
the Liu et al.8 and Meissner et al.15 secretome are represented by red and blue circles, respectively. (c) The 
overall protein-protein interaction network of the T-class secretome that belong to the highly enriched GOBP/
GOCC/GOMF is composed mostly of response signaling BP (red nodes). (d) IPA network analysis showing the 
interplaying pathways that cross-talk with high confidence (p < 0.05).
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We then performed hierarchical clustering analysis for the 1002 secreted proteins identified and quantified by 
LFQ (Supplementary Data 1). As shown in Fig. 4b, we found that 368 proteins in WT cells showed LPS-inducible, 
time-dependent increases, whereas in PHF8-KD cells 318 of these proteins did not increase, indicating that their 
LPS-inducible secretion is PHF8-dependent.
Further, approximately 254 proteins (80% of LPS-inducible secretome) showed a secretion pattern similar to 
the inflammatory phenotype-specific mRNA expression of T-class genes4; prolonged LPS stimulation caused a 
reduction in secretion of proteins that has been increased by an acute LPS stimulation (Fig. 4b, left). Therefore, we 
defined this cluster of LPS-inducible, secretory proteins as the ‘tolerizable’- or ‘T-class secretome’ (highlighted in 
green in the cluster column) (Supplementary Table 1). The remaining 64 LPS-inducible proteins (Fig. 4b, right) 
were secreted in a trend similar to the mRNA expression of the non-tolerizable (NT)-class genes (highlighted in 
yellow in the cluster column), which are clustered as the ‘NT-class secretome’ (Supplementary Table 2).
To benchmark the LFQ secretome profiling for validation, we compared our data of the Raw cell secretome 
with that of the LPS-inducible secretome from primary bone marrow-derived macrophages (BMDM)15. This 
comparison revealed 175 secretome components in common (Fig. 4c, Supplementary Table 3), 40% of which 
are cytokines and chemokines (Table 1). Further, a comparison with a more recent BMDM secretome8 revealed 
632 common components (Fig. 4c, Supplementary Table 4), 192 of which (30%) were found in the LPS-inducible 
portion including most of the cytokines and chemokines (Table 1). Some defense or wounding response-related 
proteins were found secreted upon LPS stimulation, including multiple cytokines/chemokines, complement fac-
tors, Integrin beta 2 (Itgb2), Interleukin 27 (IL27), and lymphocyte antigen 86 (Ly86), in line with a recent report 
indicating the regulatory role of PHF8 in wound healing by bone-marrow stromal cells23.
These overlapping results not only validated the accuracy of our LFQ secretome screening, but also, more 
importantly, indicated that the acute LPS-induced secretion of select cytokines/chemokines, and many other 
immune response-related proteins, is PHF8-dependent, supporting the conclusion that PHF8 is the primary 
re-programmer of chromatin modifications associated with various inflammatory genes specifically in acutely 
inflamed macrophages.
The PHF8-regulated, T-class secretome contains proteins involved in diverse extracellular pro-
cesses and pathways. Our secretome data suggested that acutely activated PHF8 regulates the secretion of 
a broad range of proteins that are involved in diverse BPs/pathways. In addition to our findings, we systematically 
explored novel pathways through which PHF8 may regulate overall immunity. By using the David bioinfor-
matics database24 in the context of Gene Ontology (GO) BPs (GOBP), GO Cellular Components (GOCC), GO 
Molecular Functions (GOMF), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, we compre-
hensively analyzed the functional categories of the LPS-inducible, PHF8-dependent, T-class secretome, which 
constitutes more than 80% of all the PHF8-dependent secretome.
The GOBP enrichment of the T-class PHF8-dependent secretome revealed defense response, response to 
wounding, immune/inflammatory response, antigen processing and presentation, regulation of comple-
ment factors, cell metabolism, glycolysis-related cell adhesion, cell migration, cell-to-cell communication, 
and T-cell migration (Supplementary Fig. 3c). The enrichment analyses of GOCC and KEGG categories from 
Cytokine/Chemokine
PHF8-dependent 
secretion
Identified in 
Meissner et al.15
Identified in 
Liu et al.8
Aimp1 ✓ ✓
Ccl2 ✓ ✓ ✓
Ccl22 ✓
Ccl3 ✓ ✓
Ccl4 ✓ ✓
Ccl5 ✓ ✓
Ccl7 ✓ ✓
Ccl9 ✓ ✓ ✓
Csf3 ✓
Cxcl10 ✓ ✓ ✓
Cxcl16 ✓ ✓
Cxcl2 ✓ ✓ ✓
Ebi3 ✓ ✓
Ifnb1 ✓
Il27 ✓ ✓
Il6 ✓ ✓
Lif ✓
Mif
Osm
Spp1 ✓
Table 1.  List of cytokines and chemokines identified in the LPS-inducible secretome in comparison with 
previous BMDM secretome studies8,15.
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the same dataset revealed similar categories of the extracellular functions that involve these secreted proteins 
(Supplementary Fig. 3d,e) Most of these proteins also showed LPS-inducible secretion from BMDMs8,15, indi-
cating the high purity of our secretome sample preparation and the accuracy of our LFQ approach. Some com-
ponents identified in the T-class PHF8-dependent secretome that represent each of the major GOBP/GOCC/
GOMF/KEGG categories are described below.
PHF8 is a broad chromatin regulator of multiple BPs and pathways primarily associated 
with the activation of adaptive immunity. PHF8 regulates processing to antigens from the products of 
apoptotic-inflamed cells. Multiple members of one of the major antigen processing/presentation complexes, the 
minichromosome maintenance (MCM) protein complex, were found as a highly enriched GOBP in the T-class 
PHF8-dependent secretome (Supplementary Fig. 3c). MCMs were expressed on the surface of different types of 
malignant/proliferative cells25 but there is little knowledge of how they are regulated during a pro-inflammatory 
response. Here, the MCM complex constituted the pathways associated with DNA replication in enriched KEGG 
pathways (Supplementary Fig. 3e). Because DNA replication is an inflammatory process26, PHF8 may regu-
late DNA metabolism of pathogens in the extracellular matrix via regulating the secretion of MCM complexes. 
Coincidently, identification of multiple nucleosome and chromosome organization-related proteins including 
Poly [ADP-ribose] polymerase-1 (PARP-1)27 in the secretome indicated that acute LPS stimulation increased cell 
death.
PHF8 regulates lysosome activation. KEGG pathway enrichment of the T-class PHF8-dependent secretome 
revealed metabolic pathways, antigen processing and presentation, and lysosomal pathways as exclusively 
T-class-specific (Supplementary Fig. 3e). Lysosome-related secreted proteins were mostly peptidase family mem-
bers, which were previously identified in LPS-induced macrophage secretome8,15,28, are part of the antigen pro-
cessing and presentation pathways and are involved in multiple immunity-related processes29. The existence of 
these lysosome-related proteins only in the T-class PHF8-dependent secretome indicates that PHF8 regulates 
lysosome formation and activity upon LPS stimulation.
PHF8 regulates antigen presentation mediated by MHC expression. In GOCC analysis (Supplementary Fig. 3d), 
we also identified major MHC components in the PHF8-dependent, T-class secretome, in agreement with MHC 
enrichment in GOBP (Supplementary Fig. 3c), implying that the activity of PHF8 is crucial for MHC expression 
on the cell surface. Expression and presentation of bacterial antigens on the cell surface by MHC1 complex in 
response to LPS is crucial for the interaction between innate immunity and adaptive immunity. MHC com-
ponents and pathogenic antigens are recognized by T cells, which leads to a cascade of inflammation-related 
responses that include death of the infected cells, death of the bacteria inside macrophage vesicles, and B cell 
activation to eliminate extracellular pathogens30.
PHF8 promotes adhesion, communication, and migration of the immune cells involved in adaptive immunity 
by regulating the secretion of the corresponding factors. We also found that PHF8 affected the LPS-induced 
secretion of select adaptive immunity regulators, including Complement factor b (Cfb), Complement factor h 
(Cfh), Interleukin enhancer binding factor 3 (Ilf3)31, Ly8632, Amyloid beta precursor protein (APP)33, integral 
membrane protein 2B (Itmb2), and metalloproteinase domain-containing protein 8 (ADAM8), and ADAM17. 
Specifically LPS-induced secretion of complement factors from macrophages is important for both recognition 
of pathogens and activation of adaptive immunity34, indicating the regulatory role of PHF8 in these BPs. Like 
Meissner et al.15, we identified ADAM17 as an LPS-induced macrophage secretome component; ADAM17 is 
an adaptive immunity regulator responsible for shedding of membrane-bound proteins, one such shed protein 
being APP35. The presence of ADAM17 with APP in the LPS-induced secretome confirms APP shedding from 
the membrane.
GOBP analysis (Supplementary Fig. 3c) also revealed some components of the PHF8-dependent T-class 
secretome are involved in cell adhesion and cell communication, including MHC complexes, serglycin 
(SRGN), Lgals3BP, intercellular adhesion molecule 1 (Icam1), Itga4, Itgb2, Cathepsin B (Ctsb), urokinase 
plasminogen-activator surface receptor (PLAUR), syndecan 4 (Sdc4), and poliovirus receptor-related 1 (Pvrl1). 
SRGN and Lgals3BP are cell-cell communication regulators activated by TLR436,37. Icam1 is a cell-surface gly-
coprotein expressed on immune cells that binds to integrins38; integrins Itga4 and Itgb2 in turn regulate cell 
migration and adaptive immunity39 and are in common with LPS-induced BMDM secretome15. Similarly, the 
released adhesion molecules Ctsb29, PLAUR40, SDC441, and Pvrl142 are involved in regulating cell migration in 
inflammation.
From a system perspective, we next used STRING43 to explore the pathway links in the PHF8-dependent, 
T-class secretome. A protein-protein interaction (PPI) network was mapped among the secreted proteins cate-
gorized in different GOBP, GOCC, and GOMF (Fig. 4d); this network was dominated by response to signaling 
BP as highlighted with red nodes. Based on these protein ‘nodes’ in the PPI network, we used IPA to identify the 
canonical pathways that share common nodes, which revealed the interplay between pathways involving antigen 
processing and presentation, complement regulation, cell adhesion, and endocytosis as the coordinator of inflam-
mation response (Fig. 4e).
PHF8 positively regulates the activation and proliferation of T cells via secretion of specific 
proteins involved in antigen presentation and activation of adaptive immunity. Our findings 
of the secreted proteins associated with the activation of adaptive immunity in the PHF8-dependent secretome 
(Fig. 4e) implicated that PHF8 positively links innate immunity and adaptive immunity. First, we next exam-
ined the LPS-induced mRNA expression of select genes encoding the corresponding T-class, PHF8-dependent 
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secreted proteins based on their relevance to antigen processing/presentation and the activation of adaptive 
immunity. Among them, Lif is a known regulator of T-cell maturation44. Similarly, the cytokine Tumor necrosis 
factor superfamily member 9 (Tnfsf9) (CD137L) regulates innate and adaptive immunity through activation of 
CD4+ T cells45. The chemokines Ccl2, Ccl7, Ccl9, Ccl22, and Cxcl16 activate adaptive immunity by promoting 
the activation and migration of T cells46. Cfb is a complement factor that regulates adaptive immunity response34. 
ADAM17 and beta-2-microglobulin (B2m) regulate T cell proliferation and differentiation30,47 while CD74 reg-
ulates cell survival in adaptive immunity48. Triggering receptor expressed on myeloid cells 2 (TREM2) is a T-cell 
regulator49 while Itga4 helps traffic leukocytes to the site of inflammation39,50. Moreover, knockout of Interfeuron 
inducible protein 30 (Ifi30) in mice causes decreased CD8+ T cell proliferation51. As the antigen processing/
presentation massagers, cathepsins regulates the formation of CD4+ T lymphocytes29. As shown in Fig. 5a, all 
of these genes showed increased mRNA expression 4 hours following LPS stimulation in WT cells while the 
LPS-induced mRNA increases were significantly lower in PHF8-KD cells. Moreover, with the exception of Ccl2 
and Ccl7, mRNA expressions of these genes decreased 8 hours after the LPS stimulation, consistent with the pat-
tern of PHF8-dependent, T-class protein secretion. In agreement with previous findings that the mRNA expres-
sion of Ccl2 and Ccl7 persisted even with the prolonged LPS stimulation52,53, identification of Ccl2 and Ccl7 at 
the protein level in T-class PHF8-dependent secretome indicates the impact of post-translational events on the 
activation of adaptive immunity, and shows how quantitative proteomic studies of extracellular proteins can help 
us immunity regulation.
Further, to determine the immediate impact of PHF8 in activating adaptive immunity, we comparatively 
measured the T-cell activation and proliferation with incubation with either WT or PHF8-KD Raw cells that were 
respectively collected at different time points following an acute LPS stimulation. Through monitoring multiple 
markers of T-cell activation including CD25, CD44, and CD69, we observed that the co-existing acute-inflamed 
WT cells promoted efficient activation of CD8+ T cells while the incubation with PHF8-KD cells gave less acti-
vated T cells (Fig. 5b, top). Similarly, more proliferated P14 CD8+ T cells were found after 6 days of co-incubation 
while PHF8-KD cells lost the ability to promote the proliferation of T cells with or without LPS stimulation 
(Fig. 5b, bottom), all indicating the regulatory function of PHF8 in the activation of adaptive immunity.
PHF8 is a G9a-antagonist that regulates gene-specific chromatin states in acute inflammation. 
Because KMT G9a is the writer of H3K9me1/2 in chronically inflamed macrophages, whereas KDM PHF8 is 
the H3K9me1/2 eraser in acutely inflamed cells, we compared the ET-specific G9a-dependent secretome8 with 
that of PHF8 during acute inflammation. Interestingly, identical proteins were secreted in an opposite manner. 
Thus LPS-induced secretion of the same set of proteins as that induced by the G9a inhibitor UNC0638 in ET8 
or as in the acutely inflamed WT cells. However, these proteins secretions were decreased in PHF8-KD cells 
(Supplementary Table 5). These results indicate an inflammatory-phenotypic, differential secretion in PHF8- ver-
sus G9a-dependent manner under either acute- or ET-inflammatory condition.
The category enrichment analysis identified 41, 33, 25, 21, 17, 14, 13, and 11 secreted proteins, respectively, 
belonging to translation, immune/inflammatory/defense response, response to wounding, cell proliferation, pos-
itive regulation of immune system, and chemotaxis GOBP/GOMFs (Supplementary Fig. 4a, 4b). More impor-
tantly, the secretion of many cytokines, chemokines, complement factors, CD14, and CD74 antigens was found to 
vary between the acute- versus chronic-inflammatory phenotype, depending upon the inflammatory-phenotypic 
activity of either PHF8 or G9a. Specifically, immune signaling molecules, select cytokines/chemokines, and anti-
gen processing/presentation factors that were identified as major components of the T-class PHF8-dependent 
secretome showed increased secretion in a strictly PHF8-dependent manner in the acutely inflamed cells, 
whereas their secretion was suppressed in the G9a-dependent ET macrophages.
Differential secretion was also observed for the proteins involved in translational processes such as tRNA 
aminoacylation, translation initiation, and translation elongation (Supplementary Fig. 4a, Supplementary 
Table 6); this observation coincided with the fact that the H3K9me1/2 eraser PHF8 acts as a transcriptional/
translational activator to regulate ribosomal RNA transcription54. Moreover, the secretion of wound response 
proteins was found in the same GOBP class (Supplementary Table 6). Some of these proteins function in cell 
proliferation, indicating that H3K9me1/2-associated secreted proteins modulate multiple BPs related to mac-
rophage cell fate decision. Further, secretion of many proteins associated with cell adhesion, cell migration, and 
movement-associated cytoskeleton was regulated antagonistically by the inflammatory-phenotypic PHF8 versus 
G9a activity. Similarly, GOCC enrichment analysis revealed inflammatory-phenotypic compartments such as 
the lysosome, Golgi-associated vesicles, and MHC complexes (Supplementary Fig. 4c); more importantly, all 
the PHF8-dependent MHC complex components were commonly identified in the G9a-suppressed secretome.
To uncover the pathways antagonistically regulated by acutely active PHF8 versus chronically active G9a, we 
performed STRING PPI analysis on the dataset of the PHF8-dependent, G9a-antagonist secretome. This analysis 
revealed multiple, interconnected subnetworks linking the signaling of immune response, translational regula-
tion, cell adhesion/communication, nucleotide binding, and lysosome/proteasome (Fig. 6a). Further, IPA canon-
ical pathway analysis revealed cell growth, cell movement, cell death, and cell-cell interaction as macrophage 
response-dependent pathways regulated by G9a and PHF8 antagonistically (Fig. 6b). Moreover, we identified 
canonicalpathways that share common protein nodes via IPA, including antigen presentation, the communica-
tion between innate and adaptive immune cells, IL-8 signaling, differential regulation of cytokine production, 
adhesion, mTOR, and Eukaryotic initiation factor 2 (EIF2) signaling indicating that PHF8 and G9a regulate 
immune response antagonistically through affecting the interplay between these pathways (Fig. 6c).
These results indicated that, in an opposing manner, G9a and PHF8 regulate the secretion of the same set of 
LPS-inducible genes by determining the methylation level of H3K9 in their associated chromatin.
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Discussion
This report is the first to document the novel function of PHF8 in chromatin-associated inflammation control 
and the concurrent activation of adaptive immunity. Coincident with our recent discovery that, in the ET mac-
rophages, the KMT G9a more actively coordinates the assembly of chromatin writer complexes in the silent 
chromatin enriched with the transcriptionally repressive histone H3K9me2 code8, we now further reveal that 
Figure 5. PHF8 promotes the LPS-induced of T cell activation and proliferation by positively regulating 
the secretion of specific classes of proteins. (a) mRNA expression of the selected genes that are related to 
antigen processing and presentation, and T cell activation in paired WT (shCON) and PHF8-KD (shPHF8) 
RAW cells. The heatmap showing the quantitative secretion pattern of these proteins found in the LFQ 
secretome analysis is given at the bottom. (b) The histograms obtained from the T-cell proliferation (top) 
and activation (bottom) assays demonstrate the PHF8 dependence of T-cell proliferation and activation. WT 
or PHF8-KD RAW cells were stimulated with 1 μg/ml LPS for 0, 8, and 24 h respectively. Then RAW cells 
are treated with mitomycin C for 30 min and fed with 30 μg/ml GP33–41 peptide for 20 min. CD8+ T cells 
isolated from P14 transgenic mouse were either labeled with CFSE for proliferation assay or kept unlabeled 
for activation assay, and co-cultured with pretreated RAW cells for 4–6 days. The population distributions of 
multiple surface markers of T cell activation and proliferation including CD25, CD44, CD69 were analyzed 
by flow cytometry. The activation marker histograms (top panel) in black line represent the T-cells pretreated 
with PHF8-KD RAW cells while the histograms in grey represent the T-cells pretreated with WT RAW cells. 
The numbers on the proliferation tables show the percentage of every division of proliferated cells among total 
CD8+ T cells (Bottom).
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PHF8, the eraser of H3K9me1/2, is the primary driver for establishing the transcriptionally active state of the 
gene-specific chromatin in acutely inflamed cells. For the first time, our data obtained at the post-translational 
level indicated that acutely active PHF8 promotes the LPS-induced secretion of the GOBP/GOMP categories 
of proteins similar to the proteins that are suppressed by G9a under the chronic inflammatory condition, we 
conclude that PHF8 is the antagonist of G9a in regulating the gene-specific chromatin state under the acute 
inflammatory condition.
As shown in Fig. 7, we postulate the mechanism of plasticity of the inflammatory phenotype-specific chro-
matin modifications that closely correlates with the transcriptional regulation of select classes of genes; the KDM 
activity of PHF8 is modulated through reversible phosphorylation by differentially activated kinases or protein 
phosphatase(s) under different inflammatory conditions. Upon LPS-induced acute inflammation, PHF8 erases 
H3K9me1/2, leading to increased secretion of T-class proteins. In contrast, in ET macrophages, PHF8 KDM 
activity is suppressed, likely by PP2Ac-mediated dephosphorylation, resulting reduced secretion of the similar set 
of the proteins. Within the chromatin associated with similar classes of genes, both PHF8 and G9a are the regu-
lators of the LPS-induced chromatin modifications but function in an opposing manner under either an acute- or 
chronic-inflammatory condition.
Interestingly, the same Ser843 (Ser880 in human, Supplementary Fig. 1d–f) of PHF8 that we found targeted 
by chronically active PP2Ac was reported to be phosphorylated by CDK2/cyclin E kinase, enhancing the KDM 
activity of PHF8 toward H3K9me2 and promoting rDNA transcription and S-phase progression of 293T, Hela, or 
U2OS cells12. Because of the transcriptionally repressive nature of chronically active PP2Ac that dephosphorylates 
Ser843 that is crucial for PHF8 KDM activity, we postulate that the KDM activity of PHF8 could be modulated in 
the phosphorylation-dependent way (not necessarily by CDK2/cyclin E kinase). The detailed mechanism under-
lying PHF8 activation is under investigation and will be reported elsewhere.
Notably, the mechanism of the gene-specific control of inflammation by TLR4-induced chromatin modifi-
cation was discovered previously by microarray analysis of LPS-induced differential gene expression. Unknown 
Figure 6. G9a and PHF8 regulate the secretion of similar sets of proteins in an opposite manner in 
chronically versus acutely inflamed macrophages. (a) Protein-protein interaction network of differentially 
regulated secretome by G9a and PHF8 antagonistically8 determined by STRING in high confidence (confidence 
score 0.7). (b) Top 10 canonical pathways regulated antagonistically by G9a and PHF8 according to the 
inflammatory phenotype determined by IPA network analysis. (c) Canonical pathways in cross talk for 
regulation of different innate immune responses.
www.nature.com/scientificreports/
1 2Scientific RepoRts | 6:24833 | DOI: 10.1038/srep24833
was exactly how different classes of genes are regulated at the epigenetic level by specific chromatin modifiers. We 
have now identified the LPS-induced, PHF8-dependent, T-class secretome at the more physiologically relevant 
protein level, thus directly and systematically extending the function of PHF8 in a broad range of biological pro-
cesses and pathways.
One of the major extracellular functions of TLR-mediated innate immunity is to instruct the activation of 
adaptive immunity through secretion of specific signaling or messenger molecules, such as selectins, chemok-
ines, cytokines, and chemokine receptors1; specifically, selectins recruit leukocytes, chemokines activate leuko-
cytes activating integrins, and the integrins regulate adhesion to the vascular endothelium39. By profiling the 
LPS-induced PHF8-dependent secretome, we have characterized novel extracellular functions controlled by 
PHF8 as a broad regulator of the innate immunity-dependent activation of adaptive immunity. This discovery 
agrees with a previous report suggesting a possible adaptive immunity function of PHF8 as a transcriptional 
activator of hairy and enhancer of split-1 (HES1), Deltex 1 (DTX1), IL7R, NOTCH3 for regulating T cell differen-
tiation55. Specifically, our secretome data indicate that PHF8 is responsible for activation of adaptive immunity by 
regulating the secretion of multiple chemoattractants as well as multiple products of MHC genes that play crucial 
roles in antigen presentation to T cell30. Our combined results indicate that PHF8 is an epigenetic regulator of a 
broad range of secreted proteins that are crucial for leukocyte/T cell activation and proliferation.
In summary, our combined strategy is a systematic, efficient, and precise way to comprehensively character-
ize the global impact of PHF8 on multiple layers of epigenetic regulation. To extend our new findings about the 
pro-inflammatory nature of PHF8, we have conducted a thorough, in-depth proteomic and secretome investiga-
tion to explore novel regulatory functions of PHF8. At the core of the transcriptional regulation, PHF8 regulates 
multiple LPS-induced extracellular biological processes, including the activation of pro-inflammatory cytokines, 
antigen presentation, MHC expression, expression/secretion of adhesion molecules, and activation of adaptive 
immunity. System-wide, our pathway/network findings based on the LPS-inducible PHF8-dependent secretome 
illustrate that acutely active PHF8 regulates the products of the innate immune response that instruct the activa-
tion of adaptive immunity, and, therefore, PHF8 is the primary epigenetic regulator bridging innate immunity 
and adaptive immunity. Under a chronic inflammatory condition, PHF8 is deactivated and is substituted by 
chronically active G9a when the same sets of the genes are suppressed/silenced. Our studies of the interchange-
able chromatin regulators under different inflammatory conditions may mechanistically derive biomarkers of 
immunopathology associated with the extremes of deregulated inflammation.
Methods
Reagents. Lipopolysaccharide (LPS), trypsin, protease inhibitor cocktails, and phosphatase inhibitor 
cocktails were purchased from Invitrogen, Promega, Sigma-Aldrich (St. Louis, MO), and Pierce, respectively. 
All culture media and fetal bovine serum (FBS) were obtained from GIBCO and dialyzed FBS was purchased 
from Invitrogen. All stable isotope-enriched amino acids, including 12C6-arginine, 13C6-arginine, and 13C615N4-
arginine, 12C6-lysine, 13C6-lysine and 13C615N2- lysine, were obtained from Cambridge Isotope and Sigma-
Aldrich. All chemicals were sequence- or HPLC-grade unless specifically indicated. Antibodies were purchased 
from Santa Cruz Biotechnology (Lmnb1 and p65), Abcam(γ -tubulin, histone H3, H3K9me2, H3K9me1, and 
H3K27me2), Millipore (PP2Ac clone 1D6), Cell Signaling (p-Iκ Ba S32, Iκ Ba, p-p65 NFκ B S536, and p65) and 
Bethyl Labs (PHF8). Bacterial clones for shRNA against PHF8 or GFP were purchased from Sigma-Aldrich. P14 
transgenic mouse, in which the CD8+ T cell encodes a T cell receptor that is specific for a peptide (P14, GP33-41) 
from the lymphocytic choriomeningitis virus (LCMV) presented by the MHC class I molecule H2-Db, is kindly 
Figure 7. The postulated mechanism underlying the gene-specific chromatin plasticity corresponding to 
the changes of immune cellular response to LPS stimulation(s). During chronic inflammation, Kme writer 
G9a and G9a-associated complexes maintain the closed chromatin architecture via H3K9me1/2 enrichment. 
Under the acute inflammatory conditions the gene-specific-repressive function of G9a is antagonized by 
the Kme eraser PHF8. HAT: histone acetyl-transferase, HDAC: histone deacetylase, ac: acetylation, and me: 
methylation.
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provided by Jason Whitmire. CD8 microbeads and MACS separation columns were purchased from Miltenyi 
Biotec. GP33-41 peptide was obtained from Anaspec. Mitomycin C was from Sigma-Aldrich.
Transfection and Stable Knockdown Cell Lines. The lentiviral plasmids pLKO.1 expressing 
shRNA-PP2Ac (targeting sequences CCAGATACAAATTACCTGTT and CGACGAGTGTTTAAGGAAATA), 
and shRNA-PHF8 (target ing sequences  CGACCCTGATAATAAGACCAA for  human and 
GCAAGATGAAACTCGGTGATT for mouse) were purchased from Sigma. A pLKO.1 empty vector (EV) with 
shRNA-GFP was used as the wild-type control (shCON). To produce virus, pLKO.1-shRNA plasmids were 
co-transfected into 293T cells with ViraPowerMix (Invitrogen) by jetPRIMETM in vitro transfection reagent 
(Polyplus). Pseudo-virus was collected 48 h post-transfection and used to transduce RAW 264.7 cells by spi-
noculation. After 48 h, 8 μg/mL puromycin was added to select puromycin-resistant clones. Stable clones were 
maintained in medium containing 4 μg/mL puromycin. The knockdown efficiency was monitored with immu-
noblotting and qPCR.
Quantitative Phosphoproteome Analysis Using AACT. The RAW 264.7 cells stably expressing shRNA 
for pLKO.1 empty vector were cultured in “L” medium and remained unstimulated (WT-N). This control cell 
line was also cultured in double-tagged “M” medium and was stimulated with 0.1 mg/mL LPS for 24 h then chal-
lenged with 1.0 mg/mL LPS for 15 min (WT-TL). RAW cells expressing shRNA for PP2Ac in double-tagged “H” 
medium were also stimulated with 0.1 mg/mL LPS for 24 h followed by a second challenge with 1.0 mg/mL LPS 
for 15 min (PP2AKD-TL). Cells were harvested and lysed in lysis buffer (8 M urea, 50 mM Tris pH 8.0, 75 mM 
NaCl, 1 mM MgCl2, 500 units Benzonase, and protease-phosphatase inhibitor cocktails). 5 mg of each lysate was 
mixed and reduced with DTT followed by alkylation with iodoacetamide (IAA). Proteins were digested first with 
endoproteinase Lys-C (Wako USA). The solution was diluted 4-fold with 25 mM Tris pH 8.0, 1 mM CaCl2 and 
further digested with trypsin (Promega). The digestion was stopped by TFA (0.4% final). Desalting was achieved 
on a Sep-Pak Light C18 cartridge (Waters). Desalted peptides were freeze-dried, resuspended in 30% acetonitrile 
(ACN)/0.1% TFA, and loaded on a 1 mL Resource 15S (GE Healthcare) column for strong cation exchange chro-
matography (SCX) with a linear gradient from 5 mM to 100 mM KCl in 30% ACN, 5 mM KH2PO4, 0.1% TFA. 
Negatively charged peptides were eluted with high salt buffer (350 mM KCl in 30% ACN, 5 mM KH2PO4, 0.1% 
TFA). The phospho-peptides were enriched directly in SCX fractions9. Briefly, 1–5 mg of 5 mm Titansphere beads 
(GL Sciences) suspended in 80% ACN/1% TFA were added to each fraction and incubated for 30 min at room 
temperature (RT). The beads were collected by centrifugation, washed three times with 150 mL 60% ACN/1% 
TFA, and transferred on to the top of a C8 disc (Empore) placed in a 200 μL pipette-tip. Bound phospho-peptides 
were eluted with 15% NH4OH/40% ACN, dried, and desalted on a StageTip containing a 4 × 1 mm C18 extrac-
tion disk (3M).
Canonical Pathway Analysis. Biological processes and molecular functions of the proteins identified as 
potential PP2Ac targets were categorized by Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, http://
www.qiagen.com/ingenuity). To focus on the phospho-peptides that are regulated downstream PP2Ac, the data-
set was trimmed to include only the peptides that showed an increase in phosphorylation in PP2AcKD-TL com-
pared to WT-TL. The canonical pathways were similarly ordered according to the ratio of phospho-peptides that 
showed an increase in PP2AcKD-TL compared to WT-TL.
RNA Preparation and Real-Time PCR. Stable cell lines were seeded into 12-well cell culture dishes and 
treated with LPS for indicated times. Total RNA was isolated using illustra RNAspin Mini Kit (GE Healthcare Life 
Sciences). First-strand cDNA was synthesized by M-MLV reverse transcriptase (Promega) and diluted 5-fold for 
qPCR. Real-time PCR was performed using Maxima SYBR Green/ROX (Thermo Scientific). All measurements 
were normalized against GAPDH as the internal control using 2−ΔΔCt method. The sequences of primers are 
included in Supplementary Table 7.
Immunoblotting Analysis. Stable cell lines from each N, NL, TL condition were harvested and lysed with 
buffer containing 0.5% NP-40, 10 mM Tris pH 7.5, 150 mM NaCl, 0.4 mM EDTA, 2 mM Na3PO4, 1x phosphatase 
inhibitor cocktail, 1x protease inhibitor cocktail.
Nuclear and Cytoplasmic Fractionation. The nuclear and cytoplasmic proteins were fractionated with 
a CelLytic NuCLEAR Extraction Kit (Sigma) according to the manufacturer’s instructions. Briefly, adherent cells 
were washed three times with PBS, scraped, and centrifuged for 5 min at 400 × g. The cell pellets were resus-
pended in hypotonic lysis buffer (10 mM Hepes pH 7.9, 1.5 mM MgCl2, and 10 mM KCl, 10 mM DTT, pro-
tease inhibitors, and phosphatase inhibitors), incubated on ice for 15 min to swell the cells, and lysed gently 
using IGEPAL CA-630 (NP40) (0.6% final). The lysates were vortexed and centrifuged immediately for 30 sec at 
10,000 × g. The supernatants (cytoplasmic fraction) were transferred to new tubes. The nuclear pellet was lysed 
with buffer containing 50 mM Tris-HCl, pH 7.5; 150 mM NaCl, 0.5% Triton-X 100, 1X phosphatase inhibitor 
cocktail, 1X protease inhibitor cocktail followed by sonication at level 3 (5 sec on, 5 sec off; twice) for the removal 
of DNA from chromatin.
Secretome Analysis. The secretome analysis method was performed as described8. Briefly, RAW 264.7 cells 
were cultured in regular DMEM medium with 10% FBS, transfected with shCON or shPHF8. 24 h prior to the 
LPS challenge, cells were washed with and cultured in serum-free DMEM containing 1 mM sodium pyruvate and 
10 mM L-glutamine with no phenol red. Cells were either left unstimulated (0) or subjected to 1 mg/mL LPS chal-
lenge for indicated hours (2, 4, 8, 24). The secreted proteins were harvested and prepared as previously described15. 
Briefly, the secretome-containing culture medium was centrifuged at 400 × g for 5 min for removal of dead cell 
www.nature.com/scientificreports/
1 4Scientific RepoRts | 6:24833 | DOI: 10.1038/srep24833
debris. The supernatant was collected with an 18-gauge needle, syringe-filtered with 0.2 μm 13 mm diameter PTFE 
filters (VWR International), transferred into fresh tubes, and kept at − 80 °C until further processed. After removal 
of the extracellular media, attached cells were lysed with 1 X SDS-loading buffer to perform immunoblots to con-
firm the inflammation phenotype. Before MS analysis, we thawed the secretome-containing medium and diluted 
in 4 X lysis buffer (8M urea, 40 mM HEPES pH 7.9) to bring the final urea concentration to 2 M. The lysate was 
then sonicated at level 3 for 5 seconds, reduced with DTT (10 mM final) for 40 min at RT, and alkylated with IAA 
(50 mM final) for 40 min in the dark at RT. Alkylation was quenched with freshly prepared thiourea (100 mM final). 
CaCl2 was added (1 mM final) before trypsin digestion overnight at RT. The digestion was quenched with TFA 
(0.5% final). Peptides were dried and resuspended at 0.1% Formic acid (FA) for MS/MS. We used reversed phase 
LC-MS/MS using a Proxeon 1000 nano LC system coupled to an LTQ Orbitrap Velos mass spectrometer (Thermo 
Scientific, San Jose, CA). The peptides were trapped using a 3 cm long 100 ◽ m i.d. C18 column at 5 μL/min 
liquid flow that was diverted from the analytical column via a vent valve while elution was performed by switching 
the valve to make the trap column in-line with a 15 cm long, 75 μm i.d., 3.5 μm, 300 Å particle C18 analytical col-
umn. The digested peptides were separated with a linear gradient of 2–35% buffer B over 240 min at a 300 nL/min 
flow rate using 0.1% FA (buffer A) and ACN with 0.1% FA (buffer B). Each secretome sample had two biological 
replicates, which were subjected to 3 single-shot independent LC-MS runs for global peptide analysis. Database 
search, peptide identification, and LFQ were performed as previously described8.
P14 CD8+ T cell proliferation and activation assays. For T cell proliferation assay, CD8+ T cells 
from P14 transgenic mouse were first isolated with CD8a microbeads according to manufactory’s instruction. 
Isolated CD8+ T cells were re-suspended in 1 mL 1640 medium and either labeled with 1 mL of the 10 μM 
Carboxyfluorescein diacetate succinimidyl ester (CFSE) for 8 min at RT for proliferation assay or kept unlabeled 
for activation assay. Cells were washed with 10 mL 1640 medium containing 10% FBS. Meanwhile WT (shCON) 
and PHF8-KD (shPHF8) RAW cells were seeded in 6-well plates and treated with 1 μg/mL LPS for 0, 8, and 
24 h followed by 50 μg/mL Mitomycin C treatment for 30 min at 37 °C. Cells were washed with 1 mL PBS twice 
and then labeled with 0.4 mL of the 30 μg/mL GP33-41 peptide in PBS for 30 min at 37 °C. The unattached pep-
tides were washed with PBS. 0.1 × 106 P14 T cells are co-cultured with 2 × 105 WT or PHF8-KD RAW cells in 
96-well plates in RPMI medium containing 50 U/mL mIL-2. The proliferation and activation of CD8+ T cells were 
assessed by flow-cytometry at day 6.
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